Bridgewater Associates’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-107,217
Closed -$1.34M 770
2023
Q2
$1.34M Sell
107,217
-4,217
-4% -$50.2K 0.01% 534
2023
Q1
$1.3M Sell
111,434
-932
-0.8% -$11.9K 0.01% 524
2022
Q4
$1.19M Sell
112,366
-36,265
-24% -$350K 0.01% 623
2022
Q3
$1.44M Sell
148,631
-2,477
-2% -$32.8K 0.01% 625
2022
Q2
$2.19M Buy
151,108
+25,351
+20% +$432K 0.01% 667
2022
Q1
$3.29M Buy
125,757
+31,662
+34% +$898K 0.01% 564
2021
Q4
$3.73M Buy
94,095
+7,695
+9% +$351K 0.02% 357
2021
Q3
$4.32M Buy
86,400
+6,181
+8% +$337K 0.02% 309
2021
Q2
$4.45M Buy
+80,219
New +$4.27M 0.03% 352

Other funds holding HCAT